Comprehensive Analysis of Remission (COMPARE) with Venlafaxine versus SSRIs
- 1 February 2008
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 63 (4) , 424-434
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatientsJournal of Psychiatric Research, 2007
- Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trialsJournal of Psychiatric Research, 2005
- Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double‐blind, randomised 6‐month comparative trial with citalopramInternational Journal of Geriatric Psychiatry, 2004
- Comparison study of venlafaxine and paroxetine for the treatment of depression in elderly Chinese inpatientsInternational Journal of Geriatric Psychiatry, 2004
- Probing the Safety of Medications in the Frail ElderlyThe Journal of Clinical Psychiatry, 2003
- A double-blind, randomized study of the efficacy and safety of venlafaxine extended release (ER) versus fluoxetine in outpatients with major depressionEuropean Neuropsychopharmacology, 2002
- A randomized, double blind, comparison of venlafaxine ER and paroxetine in outpatients with moderate to severe major depressionEuropean Neuropsychopharmacology, 2002
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Clinical acceptability of venlafaxine extended release and paroxetine in outpatients treated for depression by general practitionersEuropean Neuropsychopharmacology, 2001
- Once-Daily Venlafaxine Extended Release (XR) Compared With Fluoxetine in Outpatients With Depression and AnxietyThe Journal of Clinical Psychiatry, 1999